Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Sep 4, 2021
Open Peer Review Period: Sep 4, 2021 - Oct 30, 2021
Date Accepted: Jan 18, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

The Willingness to Pay for Telemedicine Among Patients With Chronic Diseases: Systematic Review

Chua V, Koh JH, Koh G, Tyagi S

The Willingness to Pay for Telemedicine Among Patients With Chronic Diseases: Systematic Review

J Med Internet Res 2022;24(4):e33372

DOI: 10.2196/33372

PMID: 35416779

PMCID: 9047785

The Willingness To Pay for Telemedicine By Patients With Chronic Diseases: Systematic Review

  • Valerie Chua; 
  • Jin Hean Koh; 
  • Gerald Koh; 
  • Shilpa Tyagi

ABSTRACT

Background:

Telemedicine is increasingly being leveraged on, with the need for remote access to healthcare driven by the rise of chronic disease incidence and the COVID-19 pandemic. It is also important to understand patients’ willingness to pay (WTP) for telemedicine and the factors contributing towards it as this knowledge may inform health policy planning processes like resource allocation or developing a pricing strategy for telemedicine services. Most of the published literature is focused on cost-effectiveness analysis findings to guide financing from health system’s perspective. However, there is limited exploration of the WTP from a patient’s perspective which is pertinent for sustainability of an intervention.

Objective:

To address this gap, we aimed to conduct a systematic review to describe the WTP for telemedicine interventions and to identify the factors influencing WTP among patients with chronic diseases in developed settings.

Methods:

We systematically searched 4 databases (PubMed, PsycInfo, Embase, EconLit). Two authors were involved in the appraisal. Studies were included if they reported the WTP amounts and/or identified the factors associated with patients’ WTP, included patients above 18 years of age, those diagnosed with chronic diseases and were from developed settings.

Results:

11 studies from 7 countries met the study’s inclusion criteria. The proportion of people willing to pay for telemedicine ranged from 19% to 70% across the studies, while the values for WTP amounts ranged from 0.885 USD to 821.25 USD. We found statistically significant correlation of age and distance to preferred health facility with WTP for telemedicine: while higher age was associated with lower WTP, longer travel distance was associated with higher WTP.

Conclusions:

Based on our findings, the following are recommendations which may enhance WTP: exposure to the telemedicine intervention prior to assessing WTP, lowering of telemedicine costs, and providing patient education to raise awareness on telemedicine’s benefits and address patients’ concerns. Additionally, we recommend future research be directed at standardizing the reporting of WTP studies with adoption of a common metric for WTP amount ,which may facilitate generalization of findings and effect estimates.


 Citation

Please cite as:

Chua V, Koh JH, Koh G, Tyagi S

The Willingness to Pay for Telemedicine Among Patients With Chronic Diseases: Systematic Review

J Med Internet Res 2022;24(4):e33372

DOI: 10.2196/33372

PMID: 35416779

PMCID: 9047785

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.